D-1484-2020 Class I Terminated
FDA drug recall D-1484-2020 was initiated by Mylan Institutional LLC on Jul 7, 2020 and is designated Class I. Reason for recall: Presence of Particulate Matter The recall status is terminated (terminated Jan 27, 2023). Affected quantity: 18,480 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 12, 2020
- Initiation Date
- Jul 7, 2020
- Termination Date
- Jan 27, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,480 vials
Product Description
Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50
Reason for Recall
Presence of Particulate Matter
Distribution Pattern
USA Nationwide
Code Information
Lot #: 7605112, Exp 10/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1484-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026